Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter in reply: network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema

Published:2024-05 Issue:5 Volume:13 Page:
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Watt Maureen¹^ORCID,Malmenas Mia²,Haeussler Katrin³

Affiliation:

1. Global Evidence & Outcomes Director, Takeda Development Center, 95 Hayden Ave, Lexington, MA 02421, USA

2. Senior Principal Insights, Evidence & Value – Health Economics Outcomes Research / Epidemiology, ICON plc, Stockholm Norra Bantorget, Olof Palmes Gata 29, 4th Floor, 11122, Stockholm, Sweden

3. ICON plc, Heinrich-Hertz-Str. 26, 63225, Langen, Germany

Publisher

Becaris Publishing Limited

Link

https://becarispublishing.com/doi/pdf/10.57264/cer-2024-0041

Reference10 articles.

1. Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema

2. Inhibiting plasma kallikrein for hereditary angioedema prophylaxis;Banerji A;N. Engl. J. Med.,2017

3. Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema;Aygören-Pürsün E;N. Engl. J. Med.,2018

4. Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: a Phase III randomized trial;Ohsawa I;Allergy,2021

5. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States;Banerji A;Ann. Allergy Asthma Immunol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP